Medical Department, Division of Nephrology and Internal Intensive Care Medicine, Charité Universitätsmedizin, Augustenburger Platz 1, 13353 Berlin, Germany.
Department of Neurology, Charité Universitätsmedizin, Augustenburger Platz 1, 13353 Berlin, Germany.
Resuscitation. 2018 Oct;131:121-127. doi: 10.1016/j.resuscitation.2018.07.007. Epub 2018 Jul 7.
To investigate the clinical course and early prognostic markers in cardiac arrest (CA) patients discharged from the intensive care unit (ICU) in an unresponsive wakefulness syndrome (UWS) or coma.
89 patients were identified from a prospective CA database. Follow-up was conducted by telephone interviews with legal guardians, evaluation of re-admission and rehabilitation reports assessing core elements of the coma recovery scale-revised (CRS-R). Somatosensory evoked potential (SSEP) and electroencephalography (EEG) original recordings were re-analyzed, the gray-white-matter ratio (GWR) was determined from brain computed tomography (CT) and neuron-specific enolase (NSE) serum concentrations were retrieved.
Follow-up was successful for 32/50 (64%) patients admitted between 2001-2009 and 31/39 (79%) between 2009-2015. Median ICU stay was 27 days (IQR 20-36). Neurological improvement beyond UWS was found in 2 of 63 patients. Among 61 patients with successful follow-up and no improvement, NSE serum concentrations within the reference range, SSEP amplitudes above 2.5 μV or continuous reactive EEG were found in 5%, 3% and 2% of those tested. NSE > 90 μg/L, SSEP ≤ 0.3 μV, highly malignant EEG or GWR < 1.10 were found in 44%, 49%, 35% and 22% of those tested.
Neurological recovery was rare in CA patients discharged in UWS after prolonged ICU treatment. Status epilepticus requiring prolonged deep sedation is one potential reason for delayed awakening. Sensitivity for established poor outcome parameters to predict persistent UWS early after CA was moderate. SSEP, EEG and NSE may indicate absence of severe HIE early after CA.
研究从重症监护病房(ICU)出院处于无意识觉醒综合征(UWS)或昏迷的心脏骤停(CA)患者的临床过程和早期预后标志物。
从前瞻性 CA 数据库中确定了 89 名患者。通过电话访谈对法定监护人进行随访,评估再入院和康复报告,评估昏迷恢复量表修订版(CRS-R)的核心要素。重新分析体感诱发电位(SSEP)和脑电图(EEG)原始记录,从脑计算机断层扫描(CT)确定灰白质比(GWR),并检索神经元特异性烯醇化酶(NSE)血清浓度。
成功随访了 2001-2009 年期间入院的 63 名患者中的 32 名(64%)和 2009-2015 年期间入院的 39 名患者中的 31 名(79%)。ICU 住院中位数为 27 天(IQR 20-36)。在 63 名 UWS 以外有神经改善的患者中发现了 2 名。在 61 名成功随访且无改善的患者中,在接受测试的患者中,NSE 血清浓度在参考范围内、SSEP 幅度大于 2.5μV 或连续反应性 EEG 的比例为 5%、3%和 2%。在接受测试的患者中,NSE>90μg/L、SSEP≤0.3μV、高度恶性 EEG 或 GWR<1.10 的比例分别为 44%、49%、35%和 22%。
在 ICU 治疗后长时间处于 UWS 的 CA 患者中,神经恢复很少见。需要长时间深度镇静的癫痫持续状态是导致觉醒延迟的一个潜在原因。在 CA 后早期预测持续 UWS 的既定不良预后参数的敏感性适中。SSEP、EEG 和 NSE 可能表明 CA 后早期没有严重的 HIE。